Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1967 3
1969 1
1971 6
1972 2
1974 2
1975 2
1976 1
1977 3
1978 2
1979 3
1980 9
1981 2
1982 4
1983 1
1984 1
1985 5
1986 8
1987 13
1988 22
1989 21
1990 7
1991 9
1992 8
1993 4
1994 9
1995 21
1996 11
1997 10
1998 24
1999 27
2000 29
2001 24
2002 32
2003 38
2004 44
2005 50
2006 83
2007 87
2008 108
2009 135
2010 140
2011 186
2012 202
2013 212
2014 203
2015 194
2016 185
2017 233
2018 207
2019 213
2020 211
2021 239
2022 205
2023 181
2024 179
2025 158

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,567 results

Results by year

Filters applied: . Clear all
Page 1
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation.
Min BH, Devi S, Kwon GH, Gupta H, Jeong JJ, Sharma SP, Won SM, Oh KK, Yoon SJ, Park HJ, Eom JA, Jeong MK, Hyun JY, Stalin N, Park TS, Choi J, Lee DY, Han SH, Kim DJ, Suk KT. Min BH, et al. Among authors: han sh. Gut Microbes. 2024 Jan-Dec;16(1):2307568. doi: 10.1080/19490976.2024.2307568. Epub 2024 Feb 1. Gut Microbes. 2024. PMID: 38299316 Free PMC article.
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, Lee HC, Chang K, Park MW, Bae JW, Doh JH, Cho BR, Kim HY, Kim W, Kim U, Rha SW, Hong YJ, Lee HJ, Ahn SG, Kim DI, Cho JH, Her SH, Jeon DS, Han SH, Lee JB, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee SY, Choi SH, Gwon HC, Song YB, Hahn JY; SMART-CHOICE 3 investigators. Choi KH, et al. Among authors: han sh. Lancet. 2025 Apr 12;405(10486):1252-1263. doi: 10.1016/S0140-6736(25)00449-0. Epub 2025 Mar 30. Lancet. 2025. PMID: 40174599 Clinical Trial.
Nutritional and Dietary Management of Chronic Kidney Disease Under Conservative and Preservative Kidney Care Without Dialysis.
Rhee CM, Wang AY, Biruete A, Kistler B, Kovesdy CP, Zarantonello D, Ko GJ, Piccoli GB, Garibotto G, Brunori G, Sumida K, Lambert K, Moore LW, Han SH, Narasaki Y, Kalantar-Zadeh K. Rhee CM, et al. Among authors: han sh. J Ren Nutr. 2023 Nov;33(6S):S56-S66. doi: 10.1053/j.jrn.2023.06.010. Epub 2023 Jun 30. J Ren Nutr. 2023. PMID: 37394104 Free PMC article. Review.
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.
Rovin BH, Ronco PM, Wetzels JFM, Adler SG, Ayoub I, Zaoui P, Han SH, Dudani JS, Gilbert HN, Patel UD, Manser PT, Jauch-Lembach J, Faulhaber N, Boxhammer R, Härtle S, Sprangers B. Rovin BH, et al. Among authors: han sh. Kidney Int Rep. 2024 Jun 20;9(9):2635-2647. doi: 10.1016/j.ekir.2024.06.018. eCollection 2024 Sep. Kidney Int Rep. 2024. PMID: 39291206 Free PMC article.
3,567 results